Patients with obesity or overweight and T2D saw substantially greater mean weight loss and HbA1c improvement with petrelintide versus placebo.
|Articles|November 2, 2011
Raise Your Hand to Stop Diabetes®
Author(s)American Diabetes Association
In honor of Diabetes Awareness Month, the ADA put together video clips of health care professionals pledging to stop diabetes.
Advertisement
In honor of Diabetes Awareness Month, the ADA put together video clips of health care professionals pledging to stop diabetes.
Source
:
Advertisement
Related to this article
Presented at EASD 2026, the present analysis discusses CBL-514’s apparent efficacy in reducing L2-L3 visceral fat compared to placebo.
Advertisement
Advertisement
Trending on HCPLive
1
Eplontersen Fails to Achieve Primary Endpoint, Improves KCCQ and 6MWT in ATTR-CM
2
Oral Icotrokinra Sustains UC Response Through 76 Weeks in ANTHEM-UC LTE
3
Efruxifermin Shows Durable Antifibrotic Response in MASH Through 96 Weeks
4
Tovinontrine 50 mg Improves cGMP With Minimal Effect on NT-proBNP in HFpEF
5